BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26241211)

  • 1. Sources and Targets for Drug Repurposing: Landscaping Transitions in Therapeutic Space.
    Mucke HA; Mucke E
    Assay Drug Dev Technol; 2015; 13(6):319-24. PubMed ID: 26241211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What patents tell us about drug repurposing for cancer: A landscape analysis.
    Mucke HAM
    Semin Cancer Biol; 2021 Jan; 68():3-7. PubMed ID: 31546010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive methods in drug repurposing: gold mine or just a bigger haystack?
    Cavalla D
    Drug Discov Today; 2013 Jun; 18(11-12):523-32. PubMed ID: 23270784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico repositioning of approved drugs for rare and neglected diseases.
    Ekins S; Williams AJ; Krasowski MD; Freundlich JS
    Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tecfidera(®): an approach for repurposing.
    Spencer RP
    Pharm Pat Anal; 2014 Mar; 3(2):183-98. PubMed ID: 24588595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining small-molecule screens to repurpose drugs.
    Swamidass SJ
    Brief Bioinform; 2011 Jul; 12(4):327-35. PubMed ID: 21715466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.
    Juárez-López D; Schcolnik-Cabrera A
    Arch Med Res; 2021 Apr; 52(3):243-251. PubMed ID: 33190955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repurposing and the prior art patents of competitors.
    Sternitzke C
    Drug Discov Today; 2014 Dec; 19(12):1841-7. PubMed ID: 25269415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
    Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
    Database (Oxford); 2016; 2016():. PubMed ID: 27189611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
    Cummings JL; Zhong K
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envisioning an actionable research agenda to facilitate repurposing of off-patent drugs.
    Austin CP; Mount BA; Colvis CM
    Nat Rev Drug Discov; 2021 Oct; 20(10):723-724. PubMed ID: 34045734
    [No Abstract]   [Full Text] [Related]  

  • 15. Perspectives on Drug Repurposing.
    Schcolnik-Cabrera A; Juárez-López D; Duenas-Gonzalez A
    Curr Med Chem; 2021; 28(11):2085-2099. PubMed ID: 32867630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Key Fields and Their Key Technical Points of Oncology by Patent Analysis.
    Zhang T; Chen J; Jia X
    PLoS One; 2015; 10(11):e0143573. PubMed ID: 26599967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the ophthalmology patentome: a comprehensive patent database of ocular drugs and biomarkers.
    Mucke HA; Mucke E; Mucke PM
    Pharm Pat Anal; 2013 Jan; 2(1):55-62. PubMed ID: 24236970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing and adverse event prediction using high-throughput literature analysis.
    Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.